ATE421093T1 - Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten - Google Patents

Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten

Info

Publication number
ATE421093T1
ATE421093T1 AT04787562T AT04787562T ATE421093T1 AT E421093 T1 ATE421093 T1 AT E421093T1 AT 04787562 T AT04787562 T AT 04787562T AT 04787562 T AT04787562 T AT 04787562T AT E421093 T1 ATE421093 T1 AT E421093T1
Authority
AT
Austria
Prior art keywords
hgf
growth factor
different forms
body fluid
rapid determination
Prior art date
Application number
AT04787562T
Other languages
English (en)
Inventor
Fariba Nayeri
Tayeb Nayeri
Original Assignee
Peas Inst Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peas Inst Ab filed Critical Peas Inst Ab
Application granted granted Critical
Publication of ATE421093T1 publication Critical patent/ATE421093T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04787562T 2003-09-29 2004-09-29 Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten ATE421093T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50719203P 2003-09-29 2003-09-29

Publications (1)

Publication Number Publication Date
ATE421093T1 true ATE421093T1 (de) 2009-01-15

Family

ID=34393223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04787562T ATE421093T1 (de) 2003-09-29 2004-09-29 Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten

Country Status (7)

Country Link
US (1) US20070224703A1 (de)
EP (1) EP1687636B1 (de)
AT (1) ATE421093T1 (de)
DE (1) DE602004019134D1 (de)
DK (1) DK1687636T3 (de)
ES (1) ES2321105T3 (de)
WO (1) WO2005031365A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1957102B1 (de) * 2005-11-16 2012-01-18 Fariba Nayeri Verfahren zur hemmung von krebsbildung und/oder metastasen bei einer person durch endogene c-met-liganden und -hemmer
AU2009313189B2 (en) 2008-11-10 2014-10-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2446274B1 (de) * 2009-06-26 2017-08-09 PEAS Institut AB Verfahren zur bestimmung biologisch aktiver hgf
US8865164B2 (en) 2010-11-02 2014-10-21 Kypha, Inc. Detecting complement activation
ES2564290T3 (es) * 2010-11-02 2016-03-21 Kypha, Inc. Inmunoensayo de flujo lateral para la activación de complemento y métodos de uso para evaluación del sitio de atención de trastornos asociados a complemento
WO2013042603A1 (ja) * 2011-09-20 2013-03-28 コニカミノルタホールディングス株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
SE536400C2 (sv) 2012-02-22 2013-10-08 Peas Inst Ab Ny metod för snabb detektion av hepatocyttillväxtfaktor i biologiska vätskor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321488C (en) * 1987-08-22 1993-08-24 Martin Francis Finlan Biological sensors
US5648273A (en) * 1989-12-27 1997-07-15 The United States Of America, As Represented By The Department Of Health And Human Services Hepatic growth factor receptor is the MET proto-oncogene
US5656443A (en) * 1994-07-29 1997-08-12 Long Island Jewish Medical Center Method of diagnosing bladder cancer
JP2002515724A (ja) * 1995-06-01 2002-05-28 ダナ−ファーバー キャンサー インスティテュート インコーポレイテッド ヒト血清中に見出されたジペプチジルペプチダーゼiv(cd26)の新規形態、その抗体および利用法
AU7157896A (en) * 1995-09-12 1997-04-01 Children's Hospital Medical Center Of Northern California Cystic fibrosis therapy
US5827673A (en) * 1996-08-13 1998-10-27 Akira Matsumori Method of detecting myocardial infarction
CA2394167A1 (en) * 1999-12-15 2001-06-21 Entremed, Inc. Compositions and methods for inhibiting endothelial cell proliferation
AU2001284576A1 (en) * 2000-08-28 2002-03-13 Fariba Nayeri The synergetic effects of hgf and antibacterial treatment
US20020115224A1 (en) * 2001-02-16 2002-08-22 Ulrich Rudel Method for the preparation of optical (bio)chemical sensor devices
US6730487B2 (en) * 2001-04-03 2004-05-04 Trustees Of Columbia University In The City Of New York Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy

Also Published As

Publication number Publication date
EP1687636B1 (de) 2009-01-14
DK1687636T3 (da) 2009-05-11
ES2321105T3 (es) 2009-06-02
WO2005031365A2 (en) 2005-04-07
EP1687636A2 (de) 2006-08-09
DE602004019134D1 (de) 2009-03-05
US20070224703A1 (en) 2007-09-27
WO2005031365A3 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
ATE410687T1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE241139T1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
ATE499607T1 (de) Analytentestsystem unter verwendung nichtenzymatischer analytenerkennungselemente
DE69917051D1 (de) "flow-zytometrischer" vollblut- dendritzelle- immunfunctiontest
DE69941572D1 (de) Verfahren zum electrochemischen analysieren einer analyte
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
ATE485514T1 (de) Immunoassay mit mehreren analyten
RU2011125320A (ru) Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
ATE514092T1 (de) Vorrichtung und verfahren zur simultanen bestimmung von blutgruppenantigenen
DE60021369D1 (de) Verfahren zur abschätzung eines magengeschwür-risikos
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
DE60219642D1 (de) Bestimung und quantifizierung von erythrocytenpopulationen in proben
WO2002077645A3 (en) Method for the measurement of soluble analytes
DE602007011886D1 (de) Diagnostisches Verfahren zum Nachweis von Helicobacter pylori
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE466884T1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
ATE308752T1 (de) Ein verfahren zum auffinden und/oder quantifizieren eines spezifischen ige-antikörpers in einer flüssigen probe
ATE360206T1 (de) Verfahren zur messung der gesamkonzentration eines analytes
ATE426807T1 (de) Proteomanalyse verfahren zum drogen vergleich
ATE520985T1 (de) Verfahren zur bestimmung von antigen und antikörper gegen das antigen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1687636

Country of ref document: EP